Abbvie’s RINVOQ® (upadacitinib) Approved by U.S. FDA as an Oral Treatment for Adults with Active Ankylosing Spondylitis
May 4, 2022 | BioForward Member News
Events
September 2023
Sep 26 2023
LinkedIn Live: Propelling the promise of mRNA & enabling what’s next
Sep 28 2023
BioForward Advocacy Achieves Results: Understanding the Impact of Recent State and Federal Legislation on Biohealth Companies
Sep 28 2023
WiBxTEMPO Women on Boards Panel
October 2023
Oct 10 2023
Wisconsin Innovation Awards
Oct 10 2023
2023 Wisconsin Veterans Business Conference
Oct 10 2023
ColLABorate Consilience 2023
Oct 10 - 12 2023
ColLABorate Consilience 2023
Oct 17 2023
Wisconsin Biohealth Summit
Overture Center for the Arts
Oct 25 2023
Introduction of a New Thiol-based Fluorescent Indicator to Assess Cellular Health Using Induced Pluripotent Stem Cell Derived Neurons
November 2023
Nov 28 2023
WWBIC Annual Celebration
December 2023
Dec 12 2023
2023 End of Year Celebration
No event found!